Guidepoint

How much demand could orforglipron capture in the obesity treatment market, and what factors will shape its uptake relative to existing GLP-1 options? A former primary care physician at the Perelman School of Medicine discusses prescription trends, patient switching from injectables or compounded therapies, and payer coverage dynamics. The discussion also examines tolerability, provider capacity, and key catalysts for scaling adoption. https://bit.ly/3PLOPxk

Is China’s EV market entering a new phase of growth as BEV penetration, charging infrastructure, and competitive intensity evolve? A former strategy manager at Vitesco Technologies in China assesses shifts in consumer demand, pricing sensitivity, and OEM positioning across domestic and joint-venture brands. https://bit.ly/4shFsE1

A meaningful milestone for Guidepoint, brought to life at the Nasdaq MarketSite in Times Square. We’re grateful to Nasdaq for highlighting this moment!

Last week at the #IntellusWW Summit, our team had the opportunity to connect with leaders shaping the future of pharma research.   From our booth, we had thoughtful conversations with attendees who brought a genuine curiosity for new tools and approaches, making for a highly engaging few days.   Thank you to everyone who stopped by to learn more about Guidepoint, see Guidepoint360 in action, and share how you're thinking about scaling expert knowledge within your organizations.   Great conversations - and many more to come.

The Guidepoint Library surpasses 100,000 expert transcripts, scaling real-time access to expert knowledge for better, faster decisions.   Read the full press release: https://bit.ly/4sxXF0a

If your AI isn’t grounded in real expert knowledge, it’s just guessing faster. The Guidepoint Library just passed 100,000+ expert interviews, 100% compliance reviewed, and available now inside Guidepoint360 or accessible from your enterprise AI via MCP. Add 5,000 new transcripts monthly, and you’re not just accessing information—you’re working with continuously refreshed signal. Guidepoint360 turns expert knowledge from individual datapoints into an always-on asset. See how it works: https://bit.ly/4t4SjcC

100,000 expert transcripts isn’t a milestone. It’s a living dataset. That’s 100,000 high-value interviews with doctors, executives, and domain-experts—captured, structured, and accessible through AskGP in Guidepoint360 or directly in your enterprise AI via MCP. And we’re not slowing down: • 5,000+ more added every month, including • 1,400+ live calls where you can hear it first • 100% compliance reviewed All built by a team of 300+ content specialists and former investment analysts who know what actually matters. Not more content. A living system of expert knowledge. Search it. Query it. Interrogate it. That is what real-time access looks like. To see AskGP in Action: https://bit.ly/4t4SjcC

How will AI reshape the role of brokers and carriers in P&C insurance? A former Senior Director of Global Services and Solutions at Willis Towers Watson assesses disruption risk across lines of business, the durability of broker relationships, data moats, and the impact of tools such as OpenAI’s collaboration with Tuio. https://bit.ly/4rLHuet

Can iQOS defend its leadership as pricing, tax changes, and competitor momentum reshape Japan’s heated tobacco market? A former Marketing Manager at Philip Morris International evaluates consumer switching dynamics, recent share gains by Ploom and Glo, and the effectiveness of pricing, promotions, and retail positioning. https://bit.ly/4sZDnwI

How is the treatment landscape evolving for cutaneous T-cell lymphoma as new therapies enter development? A former hematologist oncologist at H. Lee Moffitt Cancer Center and Research Institute reviews disease staging, current standards of care, and when patients transition from topical to systemic treatment. https://bit.ly/40t1eIN